IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Shasun and SeQuent to form leading animal health joint venture

9:42 AM MDT | July 15, 2013 | Natasha Alperowicz

Shasun Pharmaceuticals (Chennai, India) and SeQuent Scientific (Bangalore, India) have signed a letter of intent (LOI) to form a joint venture to develop, manufacture, and sell veterinary products, including active pharmaceutical ingredients and formulations in the global market, the companies announced today. SeQuent, and integrated pharmaceuticals company, will hold 73% in the jv and Shasun will have the balance. The establishment of the jv is subject to corporate and statutory approvals with operations expected to begin in the first quarter of 2014. On...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa